News

Hosted on MSN1mon
FDA grants 510(k) clearance to Targeted Genomics’ GlutenID test
This development marks the company's initial FDA clearance for an at-home genetic health risk (GHR) test. Leveraging a next-generation sequencing (NGS) genotyping and reporting approach ...
Yahoo Finance1mon
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
The GlutenID GHR Test uses a proprietary next generation sequencing (NGS) genotyping and reporting strategy to detect celiac genetic variants in a User’s genomic DNA isolated from at-home ...
FierceBiotech28d
Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M
The second-generation PrecivityAD2 test, launched in 2023 ... Last year the company also received backing from GHR Foundation—with $15 million for a development program targeting tau-based ...
manilatimes1mon
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
The GlutenID GHR Test uses a proprietary next generation sequencing (NGS) genotyping and reporting strategy to detect celiac genetic variants in a User's genomic DNA isolated from at-home collected ...